ADAR1 Capital Management »

Assembly Biosciences shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Assembly Biosciences (ASMB) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Assembly Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Assembly Biosciences held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Assembly Biosciences by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $485k 19k 25.60

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Assembly Biosciences

Gilead Sciences
Farallon Capital Management
RA Capital Management
Commodore Capital
Henderson Group
Vanguard Group
Frazier Life Sciences Management
Blackstone Group
Caption Management
Point72 Asset Management
Parkman Healthcare Partners
Franklin Resources
Susquehanna International
BlackRock
Renaissance Technologies

View all funds holding Assembly Biosciences